Sebastien Tabaries

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics.

Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics.

Journal: eLife

Published: May 05, 2026

PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses.

PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses.

Journal: EMBO reports

Published: August 07, 2025

Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications.

Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications.

Journal: Frontiers in oncology

Published: June 17, 2025

Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC.

Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC.

Journal: Nature

Published: April 03, 2025

Metastatic breast cancer cells are metabolically reprogrammed to maintain redox homeostasis during metastasis.

Metastatic breast cancer cells are metabolically reprogrammed to maintain redox homeostasis during metastasis.

Journal: Redox biology

Published: July 05, 2024

Antibody-mediated targeting of Claudins in cancer.

Antibody-mediated targeting of Claudins in cancer.

Journal: Frontiers in oncology

Published: October 12, 2023

Anti-Claudin-2 Antibody-Drug Conjugates for the Treatment of Colorectal Cancer Liver Metastasis.

Anti-Claudin-2 Antibody-Drug Conjugates for the Treatment of Colorectal Cancer Liver Metastasis.

Journal: Molecular cancer therapeutics

Published: June 22, 2023

CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells.

CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells.

Journal: Cancers

Published: May 18, 2022

Afadin (AF6) in cancer progression: A multidomain scaffold protein with complex and contradictory roles.

Afadin (AF6) in cancer progression: A multidomain scaffold protein with complex and contradictory roles.

Journal: BioEssays : news and reviews in molecular, cellular and developmental biology

Published: August 13, 2020

Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern.

Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern.

Journal: Communications biology

Published: August 03, 2020

Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases.

Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases.

Journal: Communications biology

Published: July 31, 2020

Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.

Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights.

Journal: British journal of cancer

Published: July 01, 2020

Showing 1-12 of 30

Last Updated: 09/26/2026